Cannabis/Hemp Isolate Extract
Phase 1Small molecule
Cannabis/Hemp Isolate Extract is one of 17 small molecule programs targeting Concussion. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
16
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
21 competitors in Concussion
#DrugCompanyPhaseTrials
1Pamelor
SSpecgx
Approved
Prometrium
FerringApproved
Tasmar
BBausch Health Americas, Inc.
Approved
Lithobid
SSolvay Pharmaceuticals
Approved
Capromorelin
UUniversity of Aarhus
Phase 2
Circadin
NNeurim Pharmaceuticals Ltd.
Phase 2
Riboflavin
CCornea and Laser Eye Institute
Phase 2
Marcaine
IInnocoll
Phase 1
Neurontin
VViatris Specialty LLC
Phase 1
Docosahexaenoic Acid
MMicelle BioPharma Inc
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- UUniversity of Regina